Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arunsingh

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 6, 2019
Moderately Hypofractionated Radiotherapy in Node-positive Prostate CancerI Mallick, A Das, M Arunsingh
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 24, 2019
Prostate Radiotherapy in India: Evolution, Practice and Challenges in the 21st CenturyV Murthy, I Mallick, M Arunsingh, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 30, 2021
Moderately Hypofractionated Radiotherapy and Androgen Deprivation Therapy for High-risk Localised Prostate Cancer: Predictors of Long-term Biochemical Control and ToxicityS Maulik, M Arunsingh, B Arun, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 17, 2018
Accuracy of Response Assessment Positron Emission Tomography-Computed Tomography Following Definitive Radiotherapy Without Chemotherapy for Head and Neck Squamous Cell CarcinomaM Arunsingh, S Vaidyanathan, K E Dyker, et al.
Indian Journal of Cancer|December 5, 2017
Continuous hyperfractionated accelerated radiotherapy using modern radiotherapy techniques for nonsmall cell lung cancer patients unsuitable for chemoradiationR K Shrimali, M Arunsingh, A Das, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 19, 2024
Quality Assurance in Radiotherapy (RT)-Specific Trials: Indian ScenarioA Mahata, S Chakraborty, S Mandal, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 12, 2017
High-dose Neural Stem Cell Radiation May Not Improve Survival in GlioblastomaR Achari, M Arunsingh, R K Badgami, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 26, 2019
A Phase I/II Study of Stereotactic Hypofractionated Once-weekly Radiation Therapy (SHORT) for Prostate CancerI Mallick, M Arunsingh, S Chakraborty, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 10, 2019
Helical Radiotherapy in Early Laryngeal Cancers Could Lead to Excess Local Recurrence: Lessons From a Phase II Prospective StudyS Chatterjee, I Mallick, S Chakraborty, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 3, 2016
Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian PopulationS Chatterjee, M Arunsingh, S Agrawal, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 6, 2019
Moderately Hypofractionated Radiotherapy in Node-positive Prostate CancerI Mallick, A Das, M Arunsingh
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 24, 2019
Prostate Radiotherapy in India: Evolution, Practice and Challenges in the 21st CenturyV Murthy, I Mallick, M Arunsingh, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 30, 2021
Moderately Hypofractionated Radiotherapy and Androgen Deprivation Therapy for High-risk Localised Prostate Cancer: Predictors of Long-term Biochemical Control and ToxicityS Maulik, M Arunsingh, B Arun, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 17, 2018
Accuracy of Response Assessment Positron Emission Tomography-Computed Tomography Following Definitive Radiotherapy Without Chemotherapy for Head and Neck Squamous Cell CarcinomaM Arunsingh, S Vaidyanathan, K E Dyker, et al.
Indian Journal of Cancer|December 5, 2017
Continuous hyperfractionated accelerated radiotherapy using modern radiotherapy techniques for nonsmall cell lung cancer patients unsuitable for chemoradiationR K Shrimali, M Arunsingh, A Das, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 19, 2024
Quality Assurance in Radiotherapy (RT)-Specific Trials: Indian ScenarioA Mahata, S Chakraborty, S Mandal, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 12, 2017
High-dose Neural Stem Cell Radiation May Not Improve Survival in GlioblastomaR Achari, M Arunsingh, R K Badgami, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 26, 2019
A Phase I/II Study of Stereotactic Hypofractionated Once-weekly Radiation Therapy (SHORT) for Prostate CancerI Mallick, M Arunsingh, S Chakraborty, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 10, 2019
Helical Radiotherapy in Early Laryngeal Cancers Could Lead to Excess Local Recurrence: Lessons From a Phase II Prospective StudyS Chatterjee, I Mallick, S Chakraborty, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 3, 2016
Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian PopulationS Chatterjee, M Arunsingh, S Agrawal, et al.
Pageof 2